Reports

Industry Research Reports

Epinephrine Auto-Injectors - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Epinephrine Auto-Injectors - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-11-03

Pages: 108 Pages

Report ld: 5375346

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Epinephrine Auto-Injectors Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

5.1%

marketSize

Market Size,2031

USD 2,014

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 1,490 million
Market Forecast in 2031(Value)
US$ 2,014 million
CAGR
5.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Epinephrine Auto-Injectors was estimated to be worth US$ 1424 million in 2024 and is forecast to a readjusted size of US$ 2014 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Epinephrine Auto-Injectors cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

n 2024, global epinephrine auto-injectors production reached approximately 5.91 million units, with an average global market price of around US$ 241 per unit.

An epinephrine auto-injector is a medical device designed for the emergency treatment of severe allergic reactions, including anaphylaxis. It delivers a dose of epinephrine (adrenaline) into the bloodstream through an injection, typically administered into the thigh muscle. The device is pre-filled with the medication, and users can self-administer the injection if they are experiencing an allergic reaction. Epinephrine works by constricting blood vessels, relaxing muscles in the lungs, and improving heart function, all of which help counteract the severe symptoms of anaphylaxis such as difficulty breathing, swelling, and low blood pressure. The upstream supply chain of epinephrine auto-injectors includes the production of raw materials such as epinephrine, plastic for the injector casing, and metal components for the needle and syringe mechanism. The downstream clients typically include healthcare providers, emergency response teams, and individuals suffering from severe allergies, such as those with known food, insect venom, or medication allergies. The industry chain also involves regulatory bodies ensuring safety and efficacy and manufacturers designing and producing the devices for both individual use and clinical settings.

The market for epinephrine auto-injectors has experienced consistent growth due to the rising prevalence of severe allergic reactions and anaphylaxis worldwide. The demand for these devices has been driven by several factors, including increased awareness about allergies, greater availability of health insurance coverage for emergency treatment, and the growing recognition of the importance of immediate response in life-threatening allergic events. Additionally, the increasing number of individuals diagnosed with allergies, especially in developed countries, has amplified the need for these life-saving devices. The market is characterized by a few key players who dominate the production and distribution of epinephrine auto-injectors, including well-established pharmaceutical companies and specialized medical device manufacturers. Despite the dominance of these players, the market has seen some competition from generic drug manufacturers, which have contributed to reducing the price point of these devices in certain regions. The cost and accessibility of epinephrine auto-injectors remain a concern, particularly in lower-income countries where healthcare infrastructure may not be as developed. Furthermore, the market faces challenges such as regulatory approval processes and the need for continuous innovation in device design and safety features. As the prevalence of allergies and anaphylaxis continues to rise, the global market for epinephrine auto-injectors is expected to expand, with increased focus on improving device ease of use, affordability, and accessibility to ensure better patient outcomes.

This report aims to provide a comprehensive presentation of the global market for Epinephrine Auto-Injectors, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Epinephrine Auto-Injectors by region & country, by Type, and by Application.

The Epinephrine Auto-Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epinephrine Auto-Injectors.

MARKET SEGMENTATION

By Company

  • Viatris
  • Teva Pharmaceutica
  • ALK Abello
  • Amneal Pharmaceuticals
  • Kaléo
  • Bioprojet Pharma
  • Bausch Health
  • Novartis Sandoz

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • 0.3 mg
  • 0.15 mg
  • 0.5 mg
  • 0.1 mg

Segment by Application

  • Under 6 Years Patients
  • 6 to 12 Years Patients
  • Over 12 Years Patients

Segment by Category

  • Hospitals and Clinics
  • Homecare

Segment by Division

  • Single Dose Autoinjectors
  • Multiple Dose Autoinjectors

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 2: Detailed analysis of Epinephrine Auto-Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 5: Sales, revenue of Epinephrine Auto-Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

marn_i1

Chapter 6: Sales, revenue of Epinephrine Auto-Injectors in country level. It provides sigmate data by Type, and by Application for each country/region.

marn_i1

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Epinephrine Auto-Injectors Product Introduction

1.2 Global Epinephrine Auto-Injectors Market Size Forecast

1.2.1 Global Epinephrine Auto-Injectors Sales Value (2020-2031)

1.2.2 Global Epinephrine Auto-Injectors Sales Volume (2020-2031)

1.2.3 Global Epinephrine Auto-Injectors Sales Price (2020-2031)

1.3 Epinephrine Auto-Injectors Market Trends & Drivers

1.3.1 Epinephrine Auto-Injectors Industry Trends

1.3.2 Epinephrine Auto-Injectors Market Drivers & Opportunity

1.3.3 Epinephrine Auto-Injectors Market Challenges

1.3.4 Epinephrine Auto-Injectors Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Epinephrine Auto-Injectors Players Revenue Ranking (2024)

2.2 Global Epinephrine Auto-Injectors Revenue by Company (2020-2025)

2.3 Global Epinephrine Auto-Injectors Players Sales Volume Ranking (2024)

2.4 Global Epinephrine Auto-Injectors Sales Volume by Company Players (2020-2025)

2.5 Global Epinephrine Auto-Injectors Average Price by Company (2020-2025)

2.6 Key Manufacturers Epinephrine Auto-Injectors Manufacturing Base and Headquarters

2.7 Key Manufacturers Epinephrine Auto-Injectors Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Epinephrine Auto-Injectors

2.9 Epinephrine Auto-Injectors Market Competitive Analysis

2.9.1 Epinephrine Auto-Injectors Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Epinephrine Auto-Injectors Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epinephrine Auto-Injectors as of 2024)

2.10 Mergers & Acquisitions, Expansion

muLu

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 0.3 mg

3.1.2 0.15 mg

3.1.3 0.5 mg

3.1.4 0.1 mg

3.2 Global Epinephrine Auto-Injectors Sales Value by Type

3.2.1 Global Epinephrine Auto-Injectors Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Epinephrine Auto-Injectors Sales Value, by Type (2020-2031)

3.2.3 Global Epinephrine Auto-Injectors Sales Value, by Type (%) (2020-2031)

3.3 Global Epinephrine Auto-Injectors Sales Volume by Type

3.3.1 Global Epinephrine Auto-Injectors Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Epinephrine Auto-Injectors Sales Volume, by Type (2020-2031)

3.3.3 Global Epinephrine Auto-Injectors Sales Volume, by Type (%) (2020-2031)

3.4 Global Epinephrine Auto-Injectors Average Price by Type (2020-2031)

muLu

4 Segmentation by End User

4.1 Introduction by End User

4.1.1 Hospitals and Clinics

4.1.2 Homecare

4.2 Global Epinephrine Auto-Injectors Sales Value by End User

4.2.1 Global Epinephrine Auto-Injectors Sales Value by End User (2020 VS 2024 VS 2031)

4.2.2 Global Epinephrine Auto-Injectors Sales Value, by End User (2020-2031)

4.2.3 Global Epinephrine Auto-Injectors Sales Value, by End User (%) (2020-2031)

4.3 Global Epinephrine Auto-Injectors Sales Volume by End User

4.3.1 Global Epinephrine Auto-Injectors Sales Volume by End User (2020 VS 2024 VS 2031)

4.3.2 Global Epinephrine Auto-Injectors Sales Volume, by End User (2020-2031)

4.3.3 Global Epinephrine Auto-Injectors Sales Volume, by End User (%) (2020-2031)

4.4 Global Epinephrine Auto-Injectors Average Price by End User (2020-2031)

muLu

5 Segmentation by Dose

5.1 Introduction by Dose

5.1.1 Single Dose Autoinjectors

5.1.2 Multiple Dose Autoinjectors

5.2 Global Epinephrine Auto-Injectors Sales Value by Dose

5.2.1 Global Epinephrine Auto-Injectors Sales Value by Dose (2020 VS 2024 VS 2031)

5.2.2 Global Epinephrine Auto-Injectors Sales Value, by Dose (2020-2031)

5.2.3 Global Epinephrine Auto-Injectors Sales Value, by Dose (%) (2020-2031)

5.3 Global Epinephrine Auto-Injectors Sales Volume by Dose

5.3.1 Global Epinephrine Auto-Injectors Sales Volume by Dose (2020 VS 2024 VS 2031)

5.3.2 Global Epinephrine Auto-Injectors Sales Volume, by Dose (2020-2031)

5.3.3 Global Epinephrine Auto-Injectors Sales Volume, by Dose (%) (2020-2031)

5.4 Global Epinephrine Auto-Injectors Average Price by Dose (2020-2031)

muLu

6 Segmentation by Application

6.1 Introduction by Application

6.1.1 Under 6 Years Patients

6.1.2 6 to 12 Years Patients

6.1.3 Over 12 Years Patients

6.2 Global Epinephrine Auto-Injectors Sales Value by Application

6.2.1 Global Epinephrine Auto-Injectors Sales Value by Application (2020 VS 2024 VS 2031)

6.2.2 Global Epinephrine Auto-Injectors Sales Value, by Application (2020-2031)

6.2.3 Global Epinephrine Auto-Injectors Sales Value, by Application (%) (2020-2031)

6.3 Global Epinephrine Auto-Injectors Sales Volume by Application

6.3.1 Global Epinephrine Auto-Injectors Sales Volume by Application (2020 VS 2024 VS 2031)

6.3.2 Global Epinephrine Auto-Injectors Sales Volume, by Application (2020-2031)

6.3.3 Global Epinephrine Auto-Injectors Sales Volume, by Application (%) (2020-2031)

6.4 Global Epinephrine Auto-Injectors Average Price by Application (2020-2031)

muLu

7 Segmentation by Region

7.1 Global Epinephrine Auto-Injectors Sales Value by Region

7.1.1 Global Epinephrine Auto-Injectors Sales Value by Region: 2020 VS 2024 VS 2031

7.1.2 Global Epinephrine Auto-Injectors Sales Value by Region (2020-2025)

7.1.3 Global Epinephrine Auto-Injectors Sales Value by Region (2026-2031)

7.1.4 Global Epinephrine Auto-Injectors Sales Value by Region (%), (2020-2031)

7.2 Global Epinephrine Auto-Injectors Sales Volume by Region

7.2.1 Global Epinephrine Auto-Injectors Sales Volume by Region: 2020 VS 2024 VS 2031

7.2.2 Global Epinephrine Auto-Injectors Sales Volume by Region (2020-2025)

7.2.3 Global Epinephrine Auto-Injectors Sales Volume by Region (2026-2031)

7.2.4 Global Epinephrine Auto-Injectors Sales Volume by Region (%), (2020-2031)

7.3 Global Epinephrine Auto-Injectors Average Price by Region (2020-2031)

7.4 North America

7.4.1 North America Epinephrine Auto-Injectors Sales Value, 2020-2031

7.4.2 North America Epinephrine Auto-Injectors Sales Value by Country (%), 2024 VS 2031

7.5 Europe

7.5.1 Europe Epinephrine Auto-Injectors Sales Value, 2020-2031

7.5.2 Europe Epinephrine Auto-Injectors Sales Value by Country (%), 2024 VS 2031

7.6 Asia Pacific

7.6.1 Asia Pacific Epinephrine Auto-Injectors Sales Value, 2020-2031

7.6.2 Asia Pacific Epinephrine Auto-Injectors Sales Value by Region (%), 2024 VS 2031

7.7 South America

7.7.1 South America Epinephrine Auto-Injectors Sales Value, 2020-2031

7.7.2 South America Epinephrine Auto-Injectors Sales Value by Country (%), 2024 VS 2031

7.8 Middle East & Africa

7.8.1 Middle East & Africa Epinephrine Auto-Injectors Sales Value, 2020-2031

7.8.2 Middle East & Africa Epinephrine Auto-Injectors Sales Value by Country (%), 2024 VS 2031

muLu

8 Segmentation by Key Countries/Regions

8.1 Key Countries/Regions Epinephrine Auto-Injectors Sales Value Growth Trends, 2020 VS 2024 VS 2031

8.2 Key Countries/Regions Epinephrine Auto-Injectors Sales Value and Sales Volume

8.2.1 Key Countries/Regions Epinephrine Auto-Injectors Sales Value, 2020-2031

8.2.2 Key Countries/Regions Epinephrine Auto-Injectors Sales Volume, 2020-2031

8.3 United States

8.3.1 United States Epinephrine Auto-Injectors Sales Value, 2020-2031

8.3.2 United States Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031

8.3.3 United States Epinephrine Auto-Injectors Sales Value by Application, 2024 VS 2031

8.4 Europe

8.4.1 Europe Epinephrine Auto-Injectors Sales Value, 2020-2031

8.4.2 Europe Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031

8.4.3 Europe Epinephrine Auto-Injectors Sales Value by Application, 2024 VS 2031

8.5 China

8.5.1 China Epinephrine Auto-Injectors Sales Value, 2020-2031

8.5.2 China Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031

8.5.3 China Epinephrine Auto-Injectors Sales Value by Application, 2024 VS 2031

8.6 Japan

8.6.1 Japan Epinephrine Auto-Injectors Sales Value, 2020-2031

8.6.2 Japan Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031

8.6.3 Japan Epinephrine Auto-Injectors Sales Value by Application, 2024 VS 2031

8.7 South Korea

8.7.1 South Korea Epinephrine Auto-Injectors Sales Value, 2020-2031

8.7.2 South Korea Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031

8.7.3 South Korea Epinephrine Auto-Injectors Sales Value by Application, 2024 VS 2031

8.8 Southeast Asia

8.8.1 Southeast Asia Epinephrine Auto-Injectors Sales Value, 2020-2031

8.8.2 Southeast Asia Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031

8.8.3 Southeast Asia Epinephrine Auto-Injectors Sales Value by Application, 2024 VS 2031

8.9 India

8.9.1 India Epinephrine Auto-Injectors Sales Value, 2020-2031

8.9.2 India Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031

8.9.3 India Epinephrine Auto-Injectors Sales Value by Application, 2024 VS 2031

muLu

9 Company Profiles

9.1 Viatris

9.1.1 Viatris Company Information

9.1.2 Viatris Introduction and Business Overview

9.1.3 Viatris Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)

9.1.4 Viatris Epinephrine Auto-Injectors Product Offerings

9.1.5 Viatris Recent Development

9.2 Teva Pharmaceutica

9.2.1 Teva Pharmaceutica Company Information

9.2.2 Teva Pharmaceutica Introduction and Business Overview

9.2.3 Teva Pharmaceutica Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)

9.2.4 Teva Pharmaceutica Epinephrine Auto-Injectors Product Offerings

9.2.5 Teva Pharmaceutica Recent Development

9.3 ALK Abello

9.3.1 ALK Abello Company Information

9.3.2 ALK Abello Introduction and Business Overview

9.3.3 ALK Abello Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)

9.3.4 ALK Abello Epinephrine Auto-Injectors Product Offerings

9.3.5 ALK Abello Recent Development

9.4 Amneal Pharmaceuticals

9.4.1 Amneal Pharmaceuticals Company Information

9.4.2 Amneal Pharmaceuticals Introduction and Business Overview

9.4.3 Amneal Pharmaceuticals Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)

9.4.4 Amneal Pharmaceuticals Epinephrine Auto-Injectors Product Offerings

9.4.5 Amneal Pharmaceuticals Recent Development

9.5 Kaléo

9.5.1 Kaléo Company Information

9.5.2 Kaléo Introduction and Business Overview

9.5.3 Kaléo Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)

9.5.4 Kaléo Epinephrine Auto-Injectors Product Offerings

9.5.5 Kaléo Recent Development

9.6 Bioprojet Pharma

9.6.1 Bioprojet Pharma Company Information

9.6.2 Bioprojet Pharma Introduction and Business Overview

9.6.3 Bioprojet Pharma Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)

9.6.4 Bioprojet Pharma Epinephrine Auto-Injectors Product Offerings

9.6.5 Bioprojet Pharma Recent Development

9.7 Bausch Health

9.7.1 Bausch Health Company Information

9.7.2 Bausch Health Introduction and Business Overview

9.7.3 Bausch Health Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)

9.7.4 Bausch Health Epinephrine Auto-Injectors Product Offerings

9.7.5 Bausch Health Recent Development

9.8 Novartis Sandoz

9.8.1 Novartis Sandoz Company Information

9.8.2 Novartis Sandoz Introduction and Business Overview

9.8.3 Novartis Sandoz Epinephrine Auto-Injectors Sales, Revenue, Price and Gross Margin (2020-2025)

9.8.4 Novartis Sandoz Epinephrine Auto-Injectors Product Offerings

9.8.5 Novartis Sandoz Recent Development

muLu

10 Industry Chain Analysis

10.1 Epinephrine Auto-Injectors Industrial Chain

10.2 Epinephrine Auto-Injectors Upstream Analysis

10.2.1 Key Raw Materials

10.2.2 Raw Materials Key Suppliers

10.2.3 Manufacturing Cost Structure

10.3 Midstream Analysis

10.4 Downstream Analysis (Customers Analysis)

10.5 Sales Model and Sales Channels

10.5.1 Epinephrine Auto-Injectors Sales Model

10.5.2 Sales Channel

10.5.3 Epinephrine Auto-Injectors Distributors

muLu

11 Research Findings and Conclusion

muLu

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Epinephrine Auto-Injectors Market Trends
Table 2. Epinephrine Auto-Injectors Market Drivers & Opportunity
Table 3. Epinephrine Auto-Injectors Market Challenges
Table 4. Epinephrine Auto-Injectors Market Restraints
Table 5. Global Epinephrine Auto-Injectors Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Epinephrine Auto-Injectors Revenue Market Share by Company (2020-2025)
Table 7. Global Epinephrine Auto-Injectors Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Epinephrine Auto-Injectors Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Epinephrine Auto-Injectors Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Epinephrine Auto-Injectors Manufacturing Base and Headquarters
Table 11. Key Manufacturers Epinephrine Auto-Injectors Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Epinephrine Auto-Injectors
Table 13. Global Epinephrine Auto-Injectors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epinephrine Auto-Injectors as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Epinephrine Auto-Injectors Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Epinephrine Auto-Injectors Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Epinephrine Auto-Injectors Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Epinephrine Auto-Injectors Sales Market Share in Value by Type (2020-2025)
Table 20. Global Epinephrine Auto-Injectors Sales Market Share in Value by Type (2026-2031)
Table 21. Global Epinephrine Auto-Injectors Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Epinephrine Auto-Injectors Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Epinephrine Auto-Injectors Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Epinephrine Auto-Injectors Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Epinephrine Auto-Injectors Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Epinephrine Auto-Injectors Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Epinephrine Auto-Injectors Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Epinephrine Auto-Injectors Sales Value by End User: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Epinephrine Auto-Injectors Sales Value by End User (2020-2025) & (US$ Million)
Table 30. Global Epinephrine Auto-Injectors Sales Value by End User (2026-2031) & (US$ Million)
Table 31. Global Epinephrine Auto-Injectors Sales Market Share in Value by End User (2020-2025)
Table 32. Global Epinephrine Auto-Injectors Sales Market Share in Value by End User (2026-2031)
Table 33. Global Epinephrine Auto-Injectors Sales Volume by End User: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Epinephrine Auto-Injectors Sales Volume by End User (2020-2025) & (K Units)
Table 35. Global Epinephrine Auto-Injectors Sales Volume by End User (2026-2031) & (K Units)
Table 36. Global Epinephrine Auto-Injectors Sales Market Share in Volume by End User (2020-2025)
Table 37. Global Epinephrine Auto-Injectors Sales Market Share in Volume by End User (2026-2031)
Table 38. Global Epinephrine Auto-Injectors Price by End User (2020-2025) & (US$/Unit)
Table 39. Global Epinephrine Auto-Injectors Price by End User (2026-2031) & (US$/Unit)
Table 40. Global Epinephrine Auto-Injectors Sales Value by Dose: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Global Epinephrine Auto-Injectors Sales Value by Dose (2020-2025) & (US$ Million)
Table 42. Global Epinephrine Auto-Injectors Sales Value by Dose (2026-2031) & (US$ Million)
Table 43. Global Epinephrine Auto-Injectors Sales Market Share in Value by Dose (2020-2025)
Table 44. Global Epinephrine Auto-Injectors Sales Market Share in Value by Dose (2026-2031)
Table 45. Global Epinephrine Auto-Injectors Sales Volume by Dose: 2020 VS 2024 VS 2031 (K Units)
Table 46. Global Epinephrine Auto-Injectors Sales Volume by Dose (2020-2025) & (K Units)
Table 47. Global Epinephrine Auto-Injectors Sales Volume by Dose (2026-2031) & (K Units)
Table 48. Global Epinephrine Auto-Injectors Sales Market Share in Volume by Dose (2020-2025)
Table 49. Global Epinephrine Auto-Injectors Sales Market Share in Volume by Dose (2026-2031)
Table 50. Global Epinephrine Auto-Injectors Price by Dose (2020-2025) & (US$/Unit)
Table 51. Global Epinephrine Auto-Injectors Price by Dose (2026-2031) & (US$/Unit)
Table 52. Global Epinephrine Auto-Injectors Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 53. Global Epinephrine Auto-Injectors Sales Value by Application (2020-2025) & (US$ Million)
Table 54. Global Epinephrine Auto-Injectors Sales Value by Application (2026-2031) & (US$ Million)
Table 55. Global Epinephrine Auto-Injectors Sales Market Share in Value by Application (2020-2025)
Table 56. Global Epinephrine Auto-Injectors Sales Market Share in Value by Application (2026-2031)
Table 57. Global Epinephrine Auto-Injectors Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 58. Global Epinephrine Auto-Injectors Sales Volume by Application (2020-2025) & (K Units)
Table 59. Global Epinephrine Auto-Injectors Sales Volume by Application (2026-2031) & (K Units)
Table 60. Global Epinephrine Auto-Injectors Sales Market Share in Volume by Application (2020-2025)
Table 61. Global Epinephrine Auto-Injectors Sales Market Share in Volume by Application (2026-2031)
Table 62. Global Epinephrine Auto-Injectors Price by Application (2020-2025) & (US$/Unit)
Table 63. Global Epinephrine Auto-Injectors Price by Application (2026-2031) & (US$/Unit)
Table 64. Global Epinephrine Auto-Injectors Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 65. Global Epinephrine Auto-Injectors Sales Value by Region (2020-2025) & (US$ Million)
Table 66. Global Epinephrine Auto-Injectors Sales Value by Region (2026-2031) & (US$ Million)
Table 67. Global Epinephrine Auto-Injectors Sales Value by Region (2020-2025) & (%)
Table 68. Global Epinephrine Auto-Injectors Sales Value by Region (2026-2031) & (%)
Table 69. Global Epinephrine Auto-Injectors Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 70. Global Epinephrine Auto-Injectors Sales Volume by Region (2020-2025) & (K Units)
Table 71. Global Epinephrine Auto-Injectors Sales Volume by Region (2026-2031) & (K Units)
Table 72. Global Epinephrine Auto-Injectors Sales Volume by Region (2020-2025) & (%)
Table 73. Global Epinephrine Auto-Injectors Sales Volume by Region (2026-2031) & (%)
Table 74. Global Epinephrine Auto-Injectors Average Price by Region (2020-2025) & (US$/Unit)
Table 75. Global Epinephrine Auto-Injectors Average Price by Region (2026-2031) & (US$/Unit)
Table 76. Key Countries/Regions Epinephrine Auto-Injectors Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 77. Key Countries/Regions Epinephrine Auto-Injectors Sales Value, (2020-2025) & (US$ Million)
Table 78. Key Countries/Regions Epinephrine Auto-Injectors Sales Value, (2026-2031) & (US$ Million)
Table 79. Key Countries/Regions Epinephrine Auto-Injectors Sales Volume, (2020-2025) & (K Units)
Table 80. Key Countries/Regions Epinephrine Auto-Injectors Sales Volume, (2026-2031) & (K Units)
Table 81. Viatris Company Information
Table 82. Viatris Introduction and Business Overview
Table 83. Viatris Epinephrine Auto-Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 84. Viatris Epinephrine Auto-Injectors Product Offerings
Table 85. Viatris Recent Development
Table 86. Teva Pharmaceutica Company Information
Table 87. Teva Pharmaceutica Introduction and Business Overview
Table 88. Teva Pharmaceutica Epinephrine Auto-Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 89. Teva Pharmaceutica Epinephrine Auto-Injectors Product Offerings
Table 90. Teva Pharmaceutica Recent Development
Table 91. ALK Abello Company Information
Table 92. ALK Abello Introduction and Business Overview
Table 93. ALK Abello Epinephrine Auto-Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 94. ALK Abello Epinephrine Auto-Injectors Product Offerings
Table 95. ALK Abello Recent Development
Table 96. Amneal Pharmaceuticals Company Information
Table 97. Amneal Pharmaceuticals Introduction and Business Overview
Table 98. Amneal Pharmaceuticals Epinephrine Auto-Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Amneal Pharmaceuticals Epinephrine Auto-Injectors Product Offerings
Table 100. Amneal Pharmaceuticals Recent Development
Table 101. Kaléo Company Information
Table 102. Kaléo Introduction and Business Overview
Table 103. Kaléo Epinephrine Auto-Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Kaléo Epinephrine Auto-Injectors Product Offerings
Table 105. Kaléo Recent Development
Table 106. Bioprojet Pharma Company Information
Table 107. Bioprojet Pharma Introduction and Business Overview
Table 108. Bioprojet Pharma Epinephrine Auto-Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Bioprojet Pharma Epinephrine Auto-Injectors Product Offerings
Table 110. Bioprojet Pharma Recent Development
Table 111. Bausch Health Company Information
Table 112. Bausch Health Introduction and Business Overview
Table 113. Bausch Health Epinephrine Auto-Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Bausch Health Epinephrine Auto-Injectors Product Offerings
Table 115. Bausch Health Recent Development
Table 116. Novartis Sandoz Company Information
Table 117. Novartis Sandoz Introduction and Business Overview
Table 118. Novartis Sandoz Epinephrine Auto-Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Novartis Sandoz Epinephrine Auto-Injectors Product Offerings
Table 120. Novartis Sandoz Recent Development
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Epinephrine Auto-Injectors Downstream Customers
Table 124. Epinephrine Auto-Injectors Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Epinephrine Auto-Injectors Product Picture
Figure 2. Global Epinephrine Auto-Injectors Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Epinephrine Auto-Injectors Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Epinephrine Auto-Injectors Sales Volume (2020-2031) & (K Units)
Figure 5. Global Epinephrine Auto-Injectors Sales Price (2020-2031) & (US$/Unit)
Figure 6. Epinephrine Auto-Injectors Report Years Considered
Figure 7. Global Epinephrine Auto-Injectors Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Epinephrine Auto-Injectors Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Epinephrine Auto-Injectors Revenue in 2024
Figure 10. Epinephrine Auto-Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. 0.3 mg Picture
Figure 12. 0.15 mg Picture
Figure 13. 0.5 mg Picture
Figure 14. 0.1 mg Picture
Figure 15. Global Epinephrine Auto-Injectors Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Epinephrine Auto-Injectors Sales Value Market Share by Type, 2024 & 2031
Figure 17. Global Epinephrine Auto-Injectors Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 18. Global Epinephrine Auto-Injectors Sales Volume Market Share by Type, 2024 & 2031
Figure 19. Global Epinephrine Auto-Injectors Price by Type (2020-2031) & (US$/Unit)
Figure 20. Hospitals and Clinics Picture
Figure 21. Homecare Picture
Figure 22. Global Epinephrine Auto-Injectors Sales Value by End User (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Epinephrine Auto-Injectors Sales Value Market Share by End User, 2024 & 2031
Figure 24. Global Epinephrine Auto-Injectors Sales Volume by End User (2020 VS 2024 VS 2031) & (K Units)
Figure 25. Global Epinephrine Auto-Injectors Sales Volume Market Share by End User, 2024 & 2031
Figure 26. Global Epinephrine Auto-Injectors Price by End User (2020-2031) & (US$/Unit)
Figure 27. Single Dose Autoinjectors Picture
Figure 28. Multiple Dose Autoinjectors Picture
Figure 29. Global Epinephrine Auto-Injectors Sales Value by Dose (2020 VS 2024 VS 2031) & (US$ Million)
Figure 30. Global Epinephrine Auto-Injectors Sales Value Market Share by Dose, 2024 & 2031
Figure 31. Global Epinephrine Auto-Injectors Sales Volume by Dose (2020 VS 2024 VS 2031) & (K Units)
Figure 32. Global Epinephrine Auto-Injectors Sales Volume Market Share by Dose, 2024 & 2031
Figure 33. Global Epinephrine Auto-Injectors Price by Dose (2020-2031) & (US$/Unit)
Figure 34. Product Picture of Under 6 Years Patients
Figure 35. Product Picture of 6 to 12 Years Patients
Figure 36. Product Picture of Over 12 Years Patients
Figure 37. Global Epinephrine Auto-Injectors Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 38. Global Epinephrine Auto-Injectors Sales Value Market Share by Application, 2024 & 2031
Figure 39. Global Epinephrine Auto-Injectors Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 40. Global Epinephrine Auto-Injectors Sales Volume Market Share by Application, 2024 & 2031
Figure 41. Global Epinephrine Auto-Injectors Price by Application (2020-2031) & (US$/Unit)
Figure 42. North America Epinephrine Auto-Injectors Sales Value (2020-2031) & (US$ Million)
Figure 43. North America Epinephrine Auto-Injectors Sales Value by Country (%), 2024 VS 2031
Figure 44. Europe Epinephrine Auto-Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 45. Europe Epinephrine Auto-Injectors Sales Value by Country (%), 2024 VS 2031
Figure 46. Asia Pacific Epinephrine Auto-Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 47. Asia Pacific Epinephrine Auto-Injectors Sales Value by Region (%), 2024 VS 2031
Figure 48. South America Epinephrine Auto-Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 49. South America Epinephrine Auto-Injectors Sales Value by Country (%), 2024 VS 2031
Figure 50. Middle East & Africa Epinephrine Auto-Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Epinephrine Auto-Injectors Sales Value by Country (%), 2024 VS 2031
Figure 52. Key Countries/Regions Epinephrine Auto-Injectors Sales Value (%), (2020-2031)
Figure 53. Key Countries/Regions Epinephrine Auto-Injectors Sales Volume (%), (2020-2031)
Figure 54. United States Epinephrine Auto-Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 55. United States Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
Figure 56. United States Epinephrine Auto-Injectors Sales Value by Application (%), 2024 VS 2031
Figure 57. Europe Epinephrine Auto-Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 58. Europe Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
Figure 59. Europe Epinephrine Auto-Injectors Sales Value by Application (%), 2024 VS 2031
Figure 60. China Epinephrine Auto-Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 61. China Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
Figure 62. China Epinephrine Auto-Injectors Sales Value by Application (%), 2024 VS 2031
Figure 63. Japan Epinephrine Auto-Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 64. Japan Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
Figure 65. Japan Epinephrine Auto-Injectors Sales Value by Application (%), 2024 VS 2031
Figure 66. South Korea Epinephrine Auto-Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 67. South Korea Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
Figure 68. South Korea Epinephrine Auto-Injectors Sales Value by Application (%), 2024 VS 2031
Figure 69. Southeast Asia Epinephrine Auto-Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 70. Southeast Asia Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
Figure 71. Southeast Asia Epinephrine Auto-Injectors Sales Value by Application (%), 2024 VS 2031
Figure 72. India Epinephrine Auto-Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 73. India Epinephrine Auto-Injectors Sales Value by Type (%), 2024 VS 2031
Figure 74. India Epinephrine Auto-Injectors Sales Value by Application (%), 2024 VS 2031
Figure 75. Epinephrine Auto-Injectors Industrial Chain
Figure 76. Epinephrine Auto-Injectors Manufacturing Cost Structure
Figure 77. Channels of Distribution (Direct Sales, and Distribution)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Epinephrine Auto-Injectors in 2025?zhanKai
The global market size of Epinephrine Auto-Injectors in 2025 was 1490 Million USD.
Which region is expected to have the highest market share?shouQi
What is the annual compound growth rate of the global Epinephrine Auto-Injectors market size from 2025 to 2031?shouQi
What was the global market size of Epinephrine Auto-Injectors in 2031?shouQi
Which companies rank high in the global Epinephrine Auto-Injectors market?shouQi
den_biaoTiZhungShi

Related Reports

Epinephrine Auto-Injectors - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-11-03

Pages: 108 Pages

Report ld: 5375346

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now